Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 8:39 pm Purchase |
2021-12-31 | 13G | SCYNEXIS, Inc. SCYX |
Avidity Partners Management LP | 2,239,278 9.300% |
259,478 (+13.11%) |
Filing History |
| 2022-02-11 5:45 pm Sale |
2021-12-31 | 13G | SCYNEXIS, Inc. SCYX |
Stonepine Capital Management, LLC | 385,650 1.600% |
-1,145,000 (-74.80%) |
Filing History |
| 2022-02-11 3:34 pm Purchase |
2021-12-31 | 13G | SCYNEXIS, Inc. SCYX |
HIRSCHMAN ORIN | 2,213,136 9.200% |
164,406 (+8.02%) |
Filing History |
| 2021-12-10 1:20 pm Purchase |
2021-11-30 | 13G | SCYNEXIS, Inc. SCYX |
FEDERATED HERMES INC. FHI |
5,449,253 19.980% |
3,319,700 (+155.89%) |
Filing History |
| 2021-11-12 06:11 am Purchase |
2021-11-09 | 13G | SCYNEXIS, Inc. SCYX |
HIRSCHMAN ORIN | 2,048,730 8.600% |
703,336 (+52.28%) |
Filing History |
| 2021-06-10 4:09 pm Purchase |
2021-06-02 | 13G | SCYNEXIS, Inc. SCYX |
HIRSCHMAN ORIN | 1,345,394 6.500% |
1,345,394 (New Position) |
Filing History |
| 2021-03-10 11:56 am Unchanged |
2021-02-28 | 13G | SCYNEXIS, Inc. SCYX |
FEDERATED HERMES INC. FHI |
2,129,553 11.050% |
0 (Unchanged) |
Filing History |
| 2021-02-16 4:06 pm Purchase |
2020-12-31 | 13G | SCYNEXIS, Inc. SCYX |
CAXTON CORP | 1,474,370 7.500% |
1,474,370 (New Position) |
Filing History |
| 2021-02-16 11:43 am Purchase |
2020-12-31 | 13G | SCYNEXIS, Inc. SCYX |
Avidity Partners Management LP | 1,979,800 9.900% |
882,546 (+80.43%) |
Filing History |
| 2021-02-12 5:09 pm Sale |
2020-12-31 | 13G | SCYNEXIS, Inc. SCYX |
Stonepine Capital Management, LLC | 1,530,650 7.700% |
-6,303 (-0.41%) |
Filing History |
| 2021-02-12 12:59 pm Purchase |
2020-12-31 | 13G | SCYNEXIS, Inc. SCYX |
FEDERATED HERMES INC. FHI |
2,129,553 19.470% |
268,512 (+14.43%) |
Filing History |
| 2021-02-11 10:59 am Purchase |
2020-12-31 | 13G | SCYNEXIS, Inc. SCYX |
Puissance Life Science Opportunities Fund VI | 255,718 2.340% |
255,718 (New Position) |
Filing History |
| 2021-01-27 4:35 pm Purchase |
2020-12-21 | 13G | SCYNEXIS, Inc. SCYX |
PERCEPTIVE ADVISORS LLC | 1,300,000 6.800% |
1,300,000 (New Position) |
Filing History |
| 2020-12-23 5:12 pm Purchase |
2020-12-17 | 13G | SCYNEXIS, Inc. SCYX |
Stonepine Capital Management, LLC | 1,536,953 7.700% |
1,536,953 (New Position) |
Filing History |
| 2020-12-23 4:15 pm Purchase |
2020-12-22 | 13G | SCYNEXIS, Inc. SCYX |
Avidity Partners Management LP | 1,097,254 9.900% |
1,097,254 (New Position) |
Filing History |